Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Connect Biopharma, a clinical-stage biopharmaceutical company focused on treatments for inflammatory diseases such as asthma and COPD, announced its participation in the H.C. Wainwright Annual Global Investment Conference. The company is advancing rademikibart, a next-generation antibody targeting IL-4Rα, currently in global clinical trials for ast…
Ambarella, a leading edge AI semiconductor company, has engaged Capgemini to help speed the development and deployment of Edge and Physical AI solutions across multiple sectors including smart infrastructure, retail, logistics, industrial automation, healthcare, and automotive. Capgemini will provide engineering, systems integration, and industry e…
Pasithea Therapeutics Corp., a clinical-stage biotech company developing PAS-004, a next-gen MEK inhibitor for diseases including neurofibromatosis type 1, announced its management team's participation in the 12th Annual Cantor Global Healthcare Conference and the H.C. Wainwright 28th Annual Global Investment Conference in September 2026. The compa…
Concrete Pumping Holdings, Inc. (Nasdaq: BBCP) announced strong Q3 fiscal 2026 results with 13% revenue growth to $116.8 million and a 17% increase in income from operations. Adjusted EBITDA rose 13% to $30.4 million. The company raised its full-year guidance, extended its share repurchase program, and initiated a quarterly cash dividend yielding 5…
Oxford Industries announced its second quarter fiscal 2026 results showing a 2.2% decline in consolidated net sales to $394 million and adjusted EPS growth to $1.34 from $1.26 last year, boosted by a $2.07 per share tariff refund. Tommy Bahama sales grew slightly, while Lilly Pulitzer and Johnny Was experienced declines, prompting the company to lo…
Nasdaq announced its monthly trading volumes for August 2026, available on its Investor Relations website. The update highlights market activity but contains no new strategic developments or financial results.
Navitas Semiconductor announced its participation in the Citi 2026 Global TMT Conference on September 8, 2026, where top executives will host a fireside chat and meet with investors to discuss its innovative GaNFast and GeneSiC power semiconductor products. The company emphasizes its leadership in GaN and SiC technologies that drive efficiency and …
Ambarella, Inc. announced financial results for Q2 fiscal 2027, showing 13.2% revenue growth year-over-year to $108.1 million and significant reduction in GAAP net loss. Non-GAAP net income increased to $8.2 million from $6.4 million a year ago. The company highlighted record edge AI revenue driven by 5nm AI SoCs and new go-to-market strategies inc…
Wave Life Sciences announced that its President and CEO, Paul Bolno, MD, MBA, will participate in an analyst-led fireside chat at the Cantor 2026 Global Healthcare Conference. The event will showcase the company's RNA medicines platform and pipeline progress, including therapies targeting obesity, alpha-1 antitrypsin deficiency, liver disease, Duch…
BioStem Technologies Inc., a regenerative medicine company specializing in perinatal tissue allograft products, announced its management will present at the H.C. Wainwright Global Investment Conference. The presentation will provide updates on its proprietary technologies, product portfolio, and clinical research initiatives.
Spyre Therapeutics, a clinical-stage biotechnology company specializing in immunology therapies, announced its management team's participation in several upcoming investor conferences in September 2026. The company aims to update investors on its pipeline developments and strategic initiatives, including investigational extended half-life antibodie…
Mama's Creations, a fresh deli prepared foods company, reported a 55% revenue increase to $54.6 million and net income doubling to $2.6 million in Q2 fiscal 2027. Adjusted EBITDA grew by nearly 69%, driven by new product launches, expanded retailer placements including Costco and Kroger, and operational leverage improvements. The company raised $10…
Lifecore Biomedical, a Nasdaq-listed contract development and manufacturing organization specializing in sterile injectable pharmaceuticals, will participate in the CPHI Global Conference in Milan from October 6-8, 2026. Company leaders will meet prospective customers to discuss process development and manufacturing services for injectable programs…
Alector, Inc., a biotechnology company focused on therapies for neurodegenerative diseases, announced management participation in two upcoming investor healthcare conferences in New York. The presentations will include fireside chats and will be webcast live, highlighting Alector's pipeline and technology such as its proprietary blood-brain barrier…
Ambarella, a US edge AI semiconductor company, announced a long-term strategic distribution agreement with Macnica to enhance the distribution, technical support, and ecosystem development of Ambarella's edge AI semiconductor products and platforms. This partnership aims to accelerate edge AI and Physical AI adoption by combining Ambarella's silico…
Immuneering Corporation, a clinical-stage oncology company focused on developing novel cancer therapies, announced management's participation in two upcoming investor conferences in New York City in September 2026. The events include fireside chats and one-on-one investor meetings, which will be webcast and archived on the company's website. Immune…
Vaxcyte, Inc., a clinical-stage vaccine company, announced the appointment of Luis Jodar, Ph.D., as Chief Medical Officer, and David McAvoy, J.D., as Chief Legal Officer, enhancing its leadership ahead of the expected topline safety, tolerability, and immunogenicity data from its VAX-31 Phase 3 OPUS-1 trial targeting invasive pneumococcal disease. …
Reliance Global Group, Inc. (Nasdaq: EZRA) announced the adoption of a one-year stockholder rights plan designed to protect stockholder value by preventing coercive or undervalued takeover attempts. The plan allows the Board time to evaluate unsolicited offers and explore alternatives to maximize shareholder returns, while not obstructing approved …
CapsoVision, Inc., a NASDAQ-listed medical technology company specializing in AI-enabled capsule endoscopy solutions, announced that its executive team will participate in the H.C. Wainwright Global Investment Conference and the ROTH Healthcare Opportunities Conference. The presentations aim to highlight its advanced imaging products for gastrointe…
Zscaler, Inc. announced strong fiscal Q4 and 2026 financial results with 25% year-over-year growth in revenue and annual recurring revenue (ARR). The company highlighted expanded platform adoption driven by innovations in AI security, Zero Trust SASE, and SecOps. Non-GAAP operating margin reached a record 24%, and guidance for fiscal 2027 projects …
LB Pharmaceuticals, a neuromedicines company focused on therapies for brain disorders, announced its executive team will participate in several upcoming investor conferences in September 2026, including Wells Fargo Healthcare Conference, H.C. Wainwright Global Investment Conference, and TD Cowen Neuropsychiatry Summit. Presentations will be availab…
Attovia Therapeutics, a clinical-stage biopharmaceutical company focused on developing next-generation biotherapeutics for immune-mediated diseases, announced management participation in upcoming investor conferences hosted by Citi and Morgan Stanley. The company highlighted its clinical and IND-enabling programs targeting multiple inflammatory and…
U.S. Global Investors, Inc. (NASDAQ: GROW) announced a net income of $3.1 million for fiscal year 2026, reversing a net loss of $334,000 the prior year. Operating revenue increased 21% to $10.3 million, supported by higher advisory fees from gold and natural resources funds and increased assets under management. The company’s Technology and Aerospa…
Frequency Electronics, Inc. announced it will hold a conference call to discuss its first quarter fiscal 2027 financial results on September 10, 2026. The company specializes in high precision timing, frequency generation, and RF control products used in space, military, and commercial applications.
Arvinas, Inc., a clinical-stage biotechnology company focusing on targeted protein degradation therapies, announced that its management team will participate in several upcoming investor conferences, including those hosted by Wells Fargo, Cantor, and Morgan Stanley. The company highlights its PROTAC platform and ongoing clinical programs targeting …
